496 related articles for article (PubMed ID: 28652242)
21. Construction and Characterization of a Recombinant Human Respiratory Syncytial Virus Encoding Enhanced Green Fluorescence Protein for Antiviral Drug Screening Assay.
Xu M; Jiao YY; Fu YH; Jiang N; Zheng YB; Yan YF; Zhang M; Zheng YP; Zhu WY; Peng XL; He JS
Biomed Res Int; 2018; 2018():8431243. PubMed ID: 29568767
[TBL] [Abstract][Full Text] [Related]
22. Antiviral and Immunomodulatory Activity of Silver Nanoparticles in Experimental RSV Infection.
Morris D; Ansar M; Speshock J; Ivanciuc T; Qu Y; Casola A; Garofalo R
Viruses; 2019 Aug; 11(8):. PubMed ID: 31398832
[TBL] [Abstract][Full Text] [Related]
23. Design and validation of small interfering RNA on respiratory syncytial virus M2-2 gene: A potential approach in RNA interference on viral replication.
Chin VK; Atika Aziz NA; Hudu SA; Harmal NS; Syahrilnizam A; Jalilian FA; Zamberi S
J Virol Methods; 2016 Oct; 236():117-125. PubMed ID: 27432115
[TBL] [Abstract][Full Text] [Related]
24. The Interferon Type I/III Response to Respiratory Syncytial Virus Infection in Airway Epithelial Cells Can Be Attenuated or Amplified by Antiviral Treatment.
McCutcheon KM; Jordan R; Mawhorter ME; Noton SL; Powers JG; Fearns R; Cihlar T; Perron M
J Virol; 2016 Feb; 90(4):1705-17. PubMed ID: 26608311
[TBL] [Abstract][Full Text] [Related]
25. Antiviral effect of cimicifugin from Cimicifuga foetida against human respiratory syncytial virus.
Wang KC; Chang JS; Lin LT; Chiang LC; Lin CC
Am J Chin Med; 2012; 40(5):1033-45. PubMed ID: 22928833
[TBL] [Abstract][Full Text] [Related]
26. 4'-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication.
Sourimant J; Lieber CM; Aggarwal M; Cox RM; Wolf JD; Yoon JJ; Toots M; Ye C; Sticher Z; Kolykhalov AA; Martinez-Sobrido L; Bluemling GR; Natchus MG; Painter GR; Plemper RK
Science; 2022 Jan; 375(6577):161-167. PubMed ID: 34855509
[TBL] [Abstract][Full Text] [Related]
27. New antiviral approaches for respiratory syncytial virus and other mononegaviruses: Inhibiting the RNA polymerase.
Fearns R; Deval J
Antiviral Res; 2016 Oct; 134():63-76. PubMed ID: 27575793
[TBL] [Abstract][Full Text] [Related]
28. Novel diversity-oriented synthesis-derived respiratory syncytial virus inhibitors identified via a high throughput replicon-based screen.
Duvall JR; VerPlank L; Ludeke B; McLeod SM; Lee MD; Vishwanathan K; Mulrooney CA; Le Quement S; Yu Q; Palmer MA; Fleming P; Fearns R; Foley MA; Scherer CA
Antiviral Res; 2016 Jul; 131():19-25. PubMed ID: 27059228
[TBL] [Abstract][Full Text] [Related]
29. ISG15 Is Upregulated in Respiratory Syncytial Virus Infection and Reduces Virus Growth through Protein ISGylation.
González-Sanz R; Mata M; Bermejo-Martín J; Álvarez A; Cortijo J; Melero JA; Martínez I
J Virol; 2016 Jan; 90(7):3428-38. PubMed ID: 26763998
[TBL] [Abstract][Full Text] [Related]
30. Antiviral activity of ginseng extract against respiratory syncytial virus infection.
Lee JS; Ko EJ; Hwang HS; Lee YN; Kwon YM; Kim MC; Kang SM
Int J Mol Med; 2014 Jul; 34(1):183-90. PubMed ID: 24756136
[TBL] [Abstract][Full Text] [Related]
31. Ribavirin treatment up-regulates antiviral gene expression via the interferon-stimulated response element in respiratory syncytial virus-infected epithelial cells.
Zhang Y; Jamaluddin M; Wang S; Tian B; Garofalo RP; Casola A; Brasier AR
J Virol; 2003 May; 77(10):5933-47. PubMed ID: 12719586
[TBL] [Abstract][Full Text] [Related]
32. Characterization of an orally available respiratory syncytial virus L protein polymerase inhibitor DZ7487.
Guo Q; Qian J; Zeng Q; Zhang L; Zhu X; Zheng J; Chen K; Liu E
Am J Transl Res; 2023; 15(3):1680-1692. PubMed ID: 37056816
[TBL] [Abstract][Full Text] [Related]
33. Oral efficacy of a respiratory syncytial virus inhibitor in rodent models of infection.
Cianci C; Genovesi EV; Lamb L; Medina I; Yang Z; Zadjura L; Yang H; D'Arienzo C; Sin N; Yu KL; Combrink K; Li Z; Colonno R; Meanwell N; Clark J; Krystal M
Antimicrob Agents Chemother; 2004 Jul; 48(7):2448-54. PubMed ID: 15215093
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of respiratory syncytial virus in vitro and in vivo by the immunosuppressive agent leflunomide.
Dunn MC; Knight DA; Waldman WJ
Antivir Ther; 2011; 16(3):309-17. PubMed ID: 21555813
[TBL] [Abstract][Full Text] [Related]
35. Antiviral activity of ethanol extract of Lophatherum gracile against respiratory syncytial virus infection.
Chen LF; Zhong YL; Luo D; Liu Z; Tang W; Cheng W; Xiong S; Li YL; Li MM
J Ethnopharmacol; 2019 Oct; 242():111575. PubMed ID: 30391397
[TBL] [Abstract][Full Text] [Related]
36. Respiratory syncytial virus-A dynamics and the effects of lumicitabine, a nucleoside viral replication inhibitor, in experimentally infected humans.
Patel K; Kirkpatrick CM; Nieforth KA; Chanda S; Zhang Q; McClure M; Fry J; Symons JA; Blatt LM; Beigelman L; DeVincenzo JP; Huntjens DR; Smith PF
J Antimicrob Chemother; 2019 Feb; 74(2):442-452. PubMed ID: 30376079
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory Effect of
Chathuranga K; Weerawardhana A; Dodantenna N; Ranathunga L; Cho WK; Ma JY; Lee JS
Viruses; 2021 Mar; 13(4):. PubMed ID: 33806073
[No Abstract] [Full Text] [Related]
38. Coptidis Rhizoma extract inhibits replication of respiratory syncytial virus in vitro and in vivo by inducing antiviral state.
Lee BH; Chathuranga K; Uddin MB; Weeratunga P; Kim MS; Cho WK; Kim HI; Ma JY; Lee JS
J Microbiol; 2017 Jun; 55(6):488-498. PubMed ID: 28551874
[TBL] [Abstract][Full Text] [Related]
39. Structure of the Respiratory Syncytial Virus Polymerase Complex.
Gilman MSA; Liu C; Fung A; Behera I; Jordan P; Rigaux P; Ysebaert N; Tcherniuk S; Sourimant J; Eléouët JF; Sutto-Ortiz P; Decroly E; Roymans D; Jin Z; McLellan JS
Cell; 2019 Sep; 179(1):193-204.e14. PubMed ID: 31495574
[TBL] [Abstract][Full Text] [Related]
40. Central Role of the NF-κB Pathway in the
Tian B; Yang J; Zhao Y; Ivanciuc T; Sun H; Wakamiya M; Garofalo RP; Brasier AR
J Virol; 2018 Jun; 92(11):. PubMed ID: 29593031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
